Institute of Biomedical Research acquired Neuro-Biotech Corp. (OTCPK:MRES) in a reverse merger transaction on January 31, 2014. Under the terms of transaction, Neuro-Biotech issued new stock, thereby giving majority control to shareholders of Institute of Biomedical Research which include Drasko Pekovic (formerly the owner of 85% of the Institute) and the Government of Montenegro (formerly the owner of 15% of the Institute).

Institute of Biomedical Research completed the acquisition of Neuro-Biotech Corp. (OTCPK:MRES) in a reverse merger transaction on January 31, 2014.